BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 12762877)

  • 1. Brain metastases treated with radiosurgery alone: an alternative to whole brain radiotherapy?
    Hasegawa T; Kondziolka D; Flickinger JC; Germanwala A; Lunsford LD
    Neurosurgery; 2003 Jun; 52(6):1318-26; discussion 1326. PubMed ID: 12762877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of stereotactic radiosurgery with and without whole-brain radiotherapy for the treatment of newly diagnosed brain metastases.
    Hall MD; McGee JL; McGee MC; Hall KA; Neils DM; Klopfenstein JD; Elwood PW
    J Neurosurg; 2014 Dec; 121 Suppl():84-90. PubMed ID: 25434941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereotactic radiosurgery for patients with multiple brain metastases: a case-matched study comparing treatment results for patients with 2-9 versus 10 or more tumors.
    Yamamoto M; Kawabe T; Sato Y; Higuchi Y; Nariai T; Watanabe S; Kasuya H
    J Neurosurg; 2014 Dec; 121 Suppl():16-25. PubMed ID: 25434933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereotactic radiosurgical treatment in 103 patients for 153 cerebral melanoma metastases.
    Selek U; Chang EL; Hassenbusch SJ; Shiu AS; Lang FF; Allen P; Weinberg J; Sawaya R; Maor MH
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1097-106. PubMed ID: 15234044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early Gamma Knife stereotactic radiosurgery to the tumor bed of resected brain metastasis for improved local control.
    Iorio-Morin C; Masson-Côté L; Ezahr Y; Blanchard J; Ebacher A; Mathieu D
    J Neurosurg; 2014 Dec; 121 Suppl():69-74. PubMed ID: 25434939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome predictors of Gamma Knife surgery for melanoma brain metastases. Clinical article.
    Liew DN; Kano H; Kondziolka D; Mathieu D; Niranjan A; Flickinger JC; Kirkwood JM; Tarhini A; Moschos S; Lunsford LD
    J Neurosurg; 2011 Mar; 114(3):769-79. PubMed ID: 20524829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereotactic radiosurgery for cerebral metastatic melanoma: factors affecting local disease control and survival.
    Mori Y; Kondziolka D; Flickinger JC; Kirkwood JM; Agarwala S; Lunsford LD
    Int J Radiat Oncol Biol Phys; 1998 Oct; 42(3):581-9. PubMed ID: 9806518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gamma Knife surgery combined with resection for treatment of a single brain metastasis: preliminary results.
    Kalani MY; Filippidis AS; Kalani MA; Sanai N; Brachman D; McBride HL; Shetter AG; Smith KA
    J Neurosurg; 2010 Dec; 113 Suppl():90-6. PubMed ID: 21121791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiosurgery in patients with renal cell carcinoma metastasis to the brain: long-term outcomes and prognostic factors influencing survival and local tumor control.
    Sheehan JP; Sun MH; Kondziolka D; Flickinger J; Lunsford LD
    J Neurosurg; 2003 Feb; 98(2):342-9. PubMed ID: 12593621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy.
    Caballero JA; Sneed PK; Lamborn KR; Ma L; Denduluri S; Nakamura JL; Barani IJ; McDermott MW
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):303-9. PubMed ID: 22079723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multiinstitutional outcome and prognostic factor analysis of radiosurgery for resectable single brain metastasis.
    Auchter RM; Lamond JP; Alexander E; Buatti JM; Chappell R; Friedman WA; Kinsella TJ; Levin AB; Noyes WR; Schultz CJ; Loeffler JS; Mehta MP
    Int J Radiat Oncol Biol Phys; 1996 Apr; 35(1):27-35. PubMed ID: 8641923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival after surgery and stereotactic radiosurgery for patients with multiple intracranial metastases: results of a single-center retrospective study.
    Smith TR; Lall RR; Lall RR; Abecassis IJ; Arnaout OM; Marymont MH; Swanson KR; Chandler JP
    J Neurosurg; 2014 Oct; 121(4):839-45. PubMed ID: 24857242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereotactic radiosurgery using the Leksell Gamma Knife Perfexion unit in the management of patients with 10 or more brain metastases.
    Grandhi R; Kondziolka D; Panczykowski D; Monaco EA; Kano H; Niranjan A; Flickinger JC; Lunsford LD
    J Neurosurg; 2012 Aug; 117(2):237-45. PubMed ID: 22631694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gamma knife radiosurgery for brain metastases: do patients benefit from adjuvant external-beam radiotherapy? An 18-month comparative analysis.
    Jawahar A; Willis BK; Smith DR; Ampil F; Datta R; Nanda A
    Stereotact Funct Neurosurg; 2002; 79(3-4):262-71. PubMed ID: 12890985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of tumor control and toxicity in patients who have survived at least one year after radiosurgery for brain metastases.
    Varlotto JM; Flickinger JC; Niranjan A; Bhatnagar AK; Kondziolka D; Lunsford LD
    Int J Radiat Oncol Biol Phys; 2003 Oct; 57(2):452-64. PubMed ID: 12957257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome predictors of gamma knife radiosurgery for renal cell carcinoma metastases.
    Kano H; Iyer A; Kondziolka D; Niranjan A; Flickinger JC; Lunsford LD
    Neurosurgery; 2011 Dec; 69(6):1232-9. PubMed ID: 21716155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linac radiosurgery versus whole brain radiotherapy for brain metastases. A survival comparison based on the RTOG recursive partitioning analysis.
    Kocher M; Maarouf M; Bendel M; Voges J; Müller RP; Sturm V
    Strahlenther Onkol; 2004 May; 180(5):263-7. PubMed ID: 15127155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early imaging radioresponsiveness of melanoma brain metastases as a predictor of patient prognosis.
    Zubatkina I; Ivanov P
    J Neurosurg; 2018 Aug; 129(2):354-365. PubMed ID: 28841116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial.
    Andrews DW; Scott CB; Sperduto PW; Flanders AE; Gaspar LE; Schell MC; Werner-Wasik M; Demas W; Ryu J; Bahary JP; Souhami L; Rotman M; Mehta MP; Curran WJ
    Lancet; 2004 May; 363(9422):1665-72. PubMed ID: 15158627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salvage whole brain radiotherapy or stereotactic radiosurgery after initial stereotactic radiosurgery for 1-4 brain metastases.
    Liu Y; Alexander BM; Chen YH; Horvath MC; Aizer AA; Claus EB; Dunn IF; Golby AJ; Johnson MD; Friesen S; Mannarino EG; Wagar M; Hacker FL; Arvold ND
    J Neurooncol; 2015 Sep; 124(3):429-37. PubMed ID: 26108659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.